Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

51 та иш

Иш: Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine

  1. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

    Lianpan Dai, Tianyi Zheng, Kun Xu +18

    Мақола20208 иқтибос
    ABI

  2. Сарлавҳасиз

    Бошқа8 иқтибос
    ABI

  3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

    Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26

    Мақола20208 иқтибос
    ABI

  4. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

    Lianpan Dai, Lidong Gao, Lifeng Tao +27

    Мақола20227 иқтибос
    ABI

  5. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

    Shilong Yang, Yan Li, Lianpan Dai +26

    Мақола20216 иқтибос
    ABI

  6. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

    Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34

    Мақола20206 иқтибос
    ABI

  7. SignalP 5.0 improves signal peptide predictions using deep neural networks

    José Juan Almagro Armenteros, Konstantinos D. Tsirigos, Casper Kaae Sønderby +5

    Мақола20193 иқтибос
    ABI

  8. Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms

    Kuo‐Chen Chou, Hong‐Bin Shen

    Мақола20083 иқтибос
    ABI

  9. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment

    Stella Amarachi Ihim, Sharafudeen Dahiru Abubakar, Zeineb Zian +4

    Шарҳ мақола20222 иқтибос
    ABI

  10. COVID-19 Response in Uzbekistan: From RT-PCR Test System to the Clinical Trial of Subunit Vaccine

    Shahlo Тurdikulova, Dilbar Dalimova, А. А. Абдуллаев +7

    БобSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks20222 иқтибос
    ABI

  11. Viral targets for vaccines against COVID-19

    Lianpan Dai, George F. Gao

    Шарҳ мақола20202 иқтибос
    ABI

  12. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

    Wanbo Tai, Lei He, Xiujuan Zhang +5

    Мақола20202 иқтибос
    ABI

  13. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

    Nikolaos C. Kyriakidis, Andrés López‐Cortés, Jorge Vásconez-González +2

    Шарҳ мақола20212 иқтибос
    ABI

  14. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI